Sarpogrelate hydrochloride, a selective 5-hydroxytryptamine(2A) antagonist, augments autologous bone marrow mononuclear cell implantation-induced improvement in endothelium-dependent vasodilation in patients with critical limb ischemia (Q43260415)
Jump to navigation
Jump to search
scientific article published in January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sarpogrelate hydrochloride, a selective 5-hydroxytryptamine(2A) antagonist, augments autologous bone marrow mononuclear cell implantation-induced improvement in endothelium-dependent vasodilation in patients with critical limb ischemia |
scientific article published in January 2010 |
Statements
1 reference
Sarpogrelate hydrochloride, a selective 5-hydroxytryptamine(2A) antagonist, augments autologous bone marrow mononuclear cell implantation-induced improvement in endothelium-dependent vasodilation in patients with critical limb ischemia (English)
1 reference
Kazuaki Chayama
1 reference
Yukihito Higashi
1 reference
Chikara Goto
1 reference
Masanori Miyazaki
1 reference
Hiroaki Sanada
1 reference
Taijiro Sueda
1 reference
1 January 2010
1 reference
1 reference
55
1 reference
1
1 reference
56-61
1 reference
Identifiers
1 reference
1 reference